Freeze-drying Market Outlook:
Freeze-drying Market size was valued at USD 1.6 billion in 2025 and is projected to reach USD 3.4 billion by the end of 2035, rising at a CAGR of 8.9 % during the forecast period, i.e., 2026 to 2035. In 2026, the industry size of freeze drying is estimated at USD 1.7 billion.
The ever-increasing demand across pharmaceuticals, biotechnology, and food preservation techniques is readily fostering upliftment of the market. Besides, the expanding contract manufacturing and outsourcing trends in pharmaceuticals are fueling the need for flexible and efficient freeze-drying solutions. U.S. FDA’s compounding quality center of excellence conducts an outsourcing facilities study on a yearly basis to understand industry challenges, quality practices, and regulatory impacts. It also revealed the study includes surveys and discussions with facilities, helping inform its policies and training programs as of the U.S. FDA October 2025 data.
Furthermore, the escalating investments in research and development, along with the growing awareness of the benefits of freeze-dried products, are providing an encouraging opportunity for adoption across various industries. GEA in September 2022 reported that it is investing a total of €70 million (USD 75 million) in a new pharmaceutical technology center in Germany, focused on freeze-drying solutions for injectable drugs such as vaccines. Besides, the 40,000 m² facility will consolidate operations and support innovation. The move will expand sustainable pharma manufacturing capabilities.
